The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOptiBiotix Health Share News (OPTI)

Share Price Information for OptiBiotix Health (OPTI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 17.75
Bid: 17.50
Ask: 18.00
Change: 0.00 (0.00%)
Spread: 0.50 (2.857%)
Open: 17.75
High: 17.75
Low: 17.75
Prev. Close: 17.75
OPTI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

OptiBiotix Health signs North America manufacturing deal with Agropur

Mon, 24th Jun 2019 07:43

(Sharecast News) - OptiBiotix Health has entered into a manufacturing, supply and distribution agreement with Agropur, it announced on Monday.The AIM-traded firm said the agreement granted Agropur an exclusive license to manufacture, supply and distribute OptiBiotix's 'SlimBiome' weight management technology in the United States, Canada and Mexico.It described Agropur, founded in 1938, as a North American "dairy industry leader" with 8,800 employees and sales of $6.7bn in 2018.It processed more than 6.2 billion litres of milk per year at its 39 plants across North America, and boasted a portfolio of brands and products including Natrel, OKA, Iögo, BiPRO, Agropur Grand Cheddar, Olympic, Farmers, Island Farms, Québon, ISO Chill and Crino.SlimBiome, meanwhile, was OptiBiotix's flagship weight management product, which would be supplied by Agropur's Customs Solutions Group as a specialised functional ingredient.It could be incorporated into a wide range of applications, including human nutrition comprising of food and beverages, dairy, dietary supplements and sports nutrition, with the exception of extruded product in cereal particulates which is a market segment serviced by Cereal Ingredients.OptiBiotix said the deal was a "strategic step" to de-risk its supply chain and extend the market reach of SlimBiome, by adding manufacturing in North America.It said it would extend the commercial opportunity for its patented weight management product into the US weight management market, which was estimated to be worth $72bn in 2019.The company said partnering with an established player with an extensive reach to companies using high-value functional ingredients into their food applications would allow end users to reduce transport and tariff costs, while shortening lead-times and granting them access to Agropur's expert advice and capabilities to create value."We are pleased to announce the signing of a manufacturing and supply agreement with Agropur," said Dr Fred Narbel, the managing director of OptiBiotix's prebiotics division."We chose Agropur due to their world leading expertise in manufacturing and distributing specialty ingredients like SlimBiome® and their reputation for supplying high quality products to the food industry."We believe working with Agropur, and similar partners around the world, provides the best opportunity of increasing our global commercial reach and catering to the growing interest we are seeing in SlimBiome® from partners worldwide."Mike Homewood, vice-president of Agropur's Custom Solutions Group, added that the collaboration with OptiBiotix Health was "well-aligned" with his company's goal to bring innovation to its customers."The manufacturing and supply of SlimBiome is a natural fit within our model of solution-focused ingredients for the food, beverage and nutrition industries. We look forward to collaborating with OptiBiotix Health in the North American market."
More News
5 Aug 2021 13:43

OptiBiotix revenues see healthy rise in first half

(Sharecast News) - Obesity, cardiovascular and diabetes-focussed life sciences company OptiBiotix Health reported first-half total invoiced sales of 'LPLDL' and 'SlimBiome' as ingredient or final product of £1.074m in an update on Thursday, representing a year-on-year increase of 44.3% and ahead of its expectations for the period.

Read more
5 Aug 2021 10:44

AIM WINNERS & LOSERS: Mkango rises on deal to wholly own Songwe Hill

AIM WINNERS & LOSERS: Mkango rises on deal to wholly own Songwe Hill

Read more
6 Jul 2021 11:30

IN BRIEF: OptiBiotix continues Asian expansion with Inscobee deal

IN BRIEF: OptiBiotix continues Asian expansion with Inscobee deal

Read more
2 Jul 2021 15:52

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

Read more
17 Jun 2021 13:21

TRADING UPDATES: Anpario performance improves; Sumo outlook confident

TRADING UPDATES: Anpario performance improves; Sumo outlook confident

Read more
17 Jun 2021 12:13

OptiBiotix operating losses narrow as revenue surges

(Sharecast News) - Life sciences company OptiBiotix Health reported a 104% improvement in its full-year revenue on Thursday, to £1.52m.

Read more
21 Apr 2021 14:44

IN BRIEF: OptiBiotix Health CEO and division chief buy shares

IN BRIEF: OptiBiotix Health CEO and division chief buy shares

Read more
16 Apr 2021 15:17

DIRECTOR DEALINGS: Tesco chair invests GBP100,000; Dechra exec sells

DIRECTOR DEALINGS: Tesco chair invests GBP100,000; Dechra exec sells

Read more
23 Mar 2021 15:04

EXECUTIVE CHANGES: BT Group Regulatory Affairs Director Ross leaves

EXECUTIVE CHANGES: BT Group Regulatory Affairs Director Ross leaves

Read more
23 Mar 2021 08:06

Optibiotix names René Kamminga as CEO of subsidiary

(Sharecast News) - Biotechnology company Optibiotix Health named René Kamminga as chief executive officer of its OptiBiotix Ltd subsidiary on Tuesday, subject to completion of normal regulatory due diligence.

Read more
17 Mar 2021 15:50

OptiBiotix expands product ranges, sees positive drug trial results

OptiBiotix expands product ranges, sees positive drug trial results

Read more
18 Feb 2021 11:13

OptiBiotix Expects To Swing To Annual Profit Thanks To Increased Sales

OptiBiotix Expects To Swing To Annual Profit Thanks To Increased Sales

Read more
2 Feb 2021 14:38

IN BRIEF: OptiBiotix Health Hires UK MP Stephen Hammond As Non-Exec

IN BRIEF: OptiBiotix Health Hires UK MP Stephen Hammond As Non-Exec

Read more
19 Jan 2021 16:30

EXECUTIVE CHANGE SUMMARY: Next CEO Wolfson Joins Board Of Deliveroo

EXECUTIVE CHANGE SUMMARY: Next CEO Wolfson Joins Board Of Deliveroo

Read more
11 Jan 2021 17:29

IN BRIEF: OptiBiotix Inks Agreement For Microbiome Products Research

IN BRIEF: OptiBiotix Inks Agreement For Microbiome Products Research

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.